Compare Elder Pharma with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ABBOTT INDIA ELDER PHARMA/
ABBOTT INDIA
 
P/E (TTM) x -0.2 51.9 - View Chart
P/BV x 0.1 16.8 0.6% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ELDER PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ABBOTT INDIA
Mar-19
ELDER PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3808,834 4.3%   
Low Rs1885,458 3.4%   
Sales per share (Unadj.) Rs491.21,731.1 28.4%  
Earnings per share (Unadj.) Rs-3.2211.9 -1.5%  
Cash flow per share (Unadj.) Rs14.4219.9 6.6%  
Dividends per share (Unadj.) Rs065.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs376.5945.2 39.8%  
Shares outstanding (eoy) m20.5421.25 96.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.1 14.0%   
Avg P/E ratio x-89.333.7 -264.7%  
P/CF ratio (eoy) x19.732.5 60.7%  
Price / Book Value ratio x0.87.6 10.0%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m5,833151,848 3.8%   
No. of employees `000NA3.5 0.0%   
Total wages/salary Rs m2,1794,356 50.0%   
Avg. sales/employee Rs ThNM10,555.5-  
Avg. wages/employee Rs ThNM1,249.9-  
Avg. net profit/employee Rs ThNM1,292.2-  
INCOME DATA
Net Sales Rs m10,08936,786 27.4%  
Other income Rs m2571,133 22.6%   
Total revenues Rs m10,34637,919 27.3%   
Gross profit Rs m-7926,047 -13.1%  
Depreciation Rs m361169 213.5%   
Interest Rs m2,75623 12,250.2%   
Profit before tax Rs m-3,6536,989 -52.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1252,485 5.0%   
Profit after tax Rs m-654,503 -1.5%  
Gross profit margin %-7.816.4 -47.7%  
Effective tax rate %-3.435.6 -9.6%   
Net profit margin %-0.612.2 -5.3%  
BALANCE SHEET DATA
Current assets Rs m9,24027,610 33.5%   
Current liabilities Rs m9,9988,569 116.7%   
Net working cap to sales %-7.551.8 -14.5%  
Current ratio x0.93.2 28.7%  
Inventory Days Days4660 76.9%  
Debtors Days Days6027 218.8%  
Net fixed assets Rs m10,1241,057 957.9%   
Share capital Rs m206213 96.8%   
"Free" reserves Rs m5,58219,873 28.1%   
Net worth Rs m7,73420,086 38.5%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88229,409 77.8%  
Interest coverage x-0.3311.6 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.3 35.2%   
Return on assets %11.815.4 76.4%  
Return on equity %-0.822.4 -3.8%  
Return on capital %22.334.9 63.9%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m307369 83.1%   
Fx outflow Rs m1254,918 2.5%   
Net fx Rs m181-4,549 -4.0%   
CASH FLOW
From Operations Rs m11,7544,991 235.5%  
From Investments Rs m-561-2,570 21.8%  
From Financial Activity Rs m-6,762-1,428 473.5%  
Net Cashflow Rs m4,432993 446.2%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 16.8 0.1 16,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.1 211.1%  
Shareholders   16,479 18,270 90.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   PFIZER  FDC  SUN PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS